(Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | (FY)Mar 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -122.60%-2.32M | 156.44%8.73M | 171.26%10.26M | 70.31%-15.46M | 66.96%-14.4M | 81.43%-52.08M | -57.25%-43.57M | -548.78%-280.4M | -84.79%-27.71M | 66.38%-43.22M |
Profit adjustment | ||||||||||
Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --28.61M | --5.86M | ---- |
Impairment and provisions: | 97.54%-644K | -533.29%-31.19M | -312.80%-26.18M | -69.46%7.2M | -20.80%12.3M | -79.33%23.57M | 177.41%15.53M | 3,643.44%114.03M | 286.32%5.6M | -112.68%-3.22M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | -98.94%4K | ---- | --378K | ---- | ---- | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | -881.36%-11.4M | -311.21%-18.16M | --1.46M | -44.63%8.6M | ---- | 177.41%15.53M | -936.76%-33.36M | 261.17%5.6M | -152.66%-3.22M |
-Other impairments and provisions | 91.96%-644K | -445.04%-19.79M | -316.48%-8.01M | -75.27%5.74M | --3.7M | -84.27%23.19M | ---- | --147.39M | ---- | ---- |
Revaluation surplus: | --0 | --0 | --0 | --0 | --0 | -74.60%8.88M | 70.38%-1.22M | 234.08%34.96M | -206.05%-4.1M | 1,623.72%10.46M |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | -74.60%8.88M | 70.38%-1.22M | 234.08%34.96M | -206.05%-4.1M | --10.46M |
Asset sale loss (gain): | --0 | --0 | --0 | -227.56%-511K | --0 | -100.88%-156K | -351.35%-93K | 110,387.50%17.68M | 131.25%37K | -99.86%16K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---511K | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | -100.88%-156K | -351.35%-93K | 110,387.50%17.68M | 131.25%37K | -58.97%16K |
Depreciation and amortization: | -2.95%691K | 5.17%1.43M | 15.21%712K | -37.82%1.36M | -49.67%618K | -41.69%2.18M | -37.41%1.23M | 77.53%3.74M | 125.78%1.96M | -4.14%2.11M |
-Depreciation | -2.95%691K | 5.17%1.43M | 15.21%712K | -37.82%1.36M | -49.67%618K | -41.69%2.18M | -37.41%1.23M | 77.53%3.74M | 125.78%1.96M | -4.14%2.11M |
Financial expense | -87.07%102K | -76.51%1.03M | -65.15%789K | -1.44%4.38M | -0.61%2.26M | -48.01%4.45M | -47.33%2.28M | 227.67%8.55M | --4.33M | 332.67%2.61M |
Special items | -17,150.00%-690K | -2,140.00%-112K | -100.00%-4K | -100.21%-5K | -100.01%-2K | -47.00%2.37M | 56.75%15.4M | -49.83%4.47M | 821.68%9.82M | 1,173.49%8.91M |
Operating profit before the change of operating capital | 80.17%-2.86M | -560.97%-20.12M | -1,934.73%-14.42M | 71.80%-3.04M | 107.52%786K | 84.21%-10.8M | -148.44%-10.45M | -206.12%-68.37M | 71.21%-4.21M | -144.13%-22.34M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | 207.11%1.63M | -1,713.65%-9.43M | 67.54%-1.52M | 58.30%-520K | 53.78%-4.68M | -102.11%-1.25M | -354.97%-10.13M | 1,259.20%59.13M | -56.57%3.97M | -154.47%-5.1M |
Accounts receivable (increase)decrease | -102.65%-104K | 20.68%3.67M | 62.08%3.92M | -79.63%3.04M | -81.08%2.42M | 150.46%14.91M | 9.01%12.78M | 1,159.25%5.95M | 178.34%11.72M | -105.17%-562K |
Accounts payable increase (decrease) | -26.79%959K | 166.87%4.37M | 1,259.29%1.31M | 108.59%1.64M | 99.35%-113K | -439.03%-19.05M | -970.81%-17.32M | 38.26%5.62M | -150.90%-1.62M | 172.66%4.06M |
Cash from business operations | 96.49%-376K | -2,040.49%-21.52M | -573.29%-10.71M | 106.85%1.11M | 93.67%-1.59M | -793.91%-16.18M | -354.41%-25.12M | 109.74%2.33M | 411.77%9.87M | -128.54%-23.93M |
Other taxs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 176.05%962K |
Net cash from operations | 96.49%-376K | -2,040.49%-21.52M | -573.29%-10.71M | 106.85%1.11M | 93.67%-1.59M | -793.91%-16.18M | -354.41%-25.12M | 110.15%2.33M | 241.59%9.87M | -127.81%-22.97M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 17,150.00%690K | 706,500.00%35.33M | 100.00%4K | -28.57%5K | -60.00%2K | -98.11%7K | -97.79%5K | 41.06%371K | 653.33%226K | -68.31%263K |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 138.33%345K |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | -99.71%156K | --143K | 264,935.00%53.01M | ---- | 0.00%20K |
Purchase of fixed assets | ---- | 43.48%-26K | ---- | -84.00%-46K | ---- | 99.31%-25K | 99.21%-24K | -237.69%-3.62M | -194.11%-3.04M | -64.17%-1.07M |
Sale of subsidiaries | ---- | ---- | ---- | ---19K | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---6M | ---6M | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 45.05%-4.61M | 34.02%-4.61M | 90.16%-8.39M |
Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---50M |
Net cash from investment operations | 17,150.00%690K | 58,940.00%35.3M | 100.00%4K | -143.48%-60K | -98.39%2K | -99.65%138K | 100.92%124K | 166.54%39.15M | -76.06%-13.43M | 26.02%-58.84M |
Net cash before financing | 102.93%314K | 1,214.01%13.78M | -573.88%-10.71M | 106.54%1.05M | 93.64%-1.59M | -138.68%-16.04M | -602.78%-24.99M | 150.70%41.48M | 24.93%-3.56M | -2,760.42%-81.81M |
Cash flow from financing activities | ||||||||||
New borrowing | --1M | 9,900.00%2M | ---- | -99.93%20K | ---- | 1.27%28M | ---- | -52.49%27.65M | --24M | 66.29%58.2M |
Refund | ---- | -892.53%-29.78M | ---25.98M | 89.76%-3M | ---- | 45.68%-29.29M | 41.07%-3.16M | ---53.93M | ---5.36M | ---- |
Issuing shares | ---- | 526.98%32.77M | 540.94%35.16M | -63.70%5.23M | -40.68%5.49M | --14.4M | --9.25M | ---- | ---- | ---- |
Interest paid - financing | 98.88%-15K | 97.96%-67K | 39.31%-1.35M | 25.27%-3.29M | -867.69%-2.22M | 41.28%-4.4M | 91.46%-229K | -187.01%-7.49M | ---2.68M | -332.67%-2.61M |
Issuance expenses and redemption of securities expenses | ---- | ---- | -822.78%-2.39M | ---- | 40.05%-259K | ---690K | ---432K | ---- | ---- | ---- |
Other items of the financing business | 2.85%-614K | -81.44%-1.23M | -80.57%-632K | 45.51%-679K | 62.24%-350K | 14.36%-1.25M | -117.10%-927K | ---1.46M | ---427K | ---- |
Net cash from financing operations | -92.30%371K | 315.19%3.7M | 81.10%4.82M | -125.37%-1.72M | -40.88%2.66M | 119.23%6.77M | -71.02%4.5M | -163.36%-35.22M | --15.53M | 9,319.07%55.59M |
Effect of rate | -75.68%-715K | 214.71%195K | ---407K | 78.62%-170K | ---- | -280.38%-795K | 96.96%-8K | -703.85%-209K | -204.37%-263K | 98.78%-26K |
Net Cash | 111.63%685K | 2,713.00%17.48M | -649.35%-5.89M | 92.78%-669K | 105.23%1.07M | -248.19%-9.27M | -271.11%-20.49M | 123.87%6.26M | 352.80%11.98M | -1,160.56%-26.22M |
Begining period cash | 74.95%41.26M | -3.44%23.59M | -3.44%23.59M | -29.19%24.42M | -29.19%24.42M | 21.26%34.49M | 21.26%34.49M | -47.99%28.44M | -47.99%28.44M | 0.63%54.69M |
Cash at the end | 138.48%41.23M | 74.95%41.26M | -32.19%17.29M | -3.44%23.59M | 82.21%25.5M | -29.19%24.42M | -65.15%13.99M | 21.26%34.49M | -20.01%40.16M | -47.99%28.44M |
Cash balance analysis | ||||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data